MARC details
000 -LEADER |
fixed length control field |
01630pam a2200397 i 4500 |
001 - CONTROL NUMBER |
control field |
9916374113406676 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
TH-BaNU |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20220909114827.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
211104s2014 caua b 001 0 eng |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
LC control number |
2013043146 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9780123820303 (alk. paper) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
0123820308 (alk. paper) |
040 ## - CATALOGING SOURCE |
Original cataloging agency |
DLC |
Language of cataloging |
eng |
Description conventions |
rda |
Transcribing agency |
DLC |
Modifying agency |
YDXCP |
-- |
IMN |
-- |
TH-BaNU |
041 0# - LANGUAGE CODE |
Language code of text/sound track or separate title |
eng |
042 ## - AUTHENTICATION CODE |
Authentication code |
pcc |
-- |
nlmcopyc |
060 00 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
Classification number |
QV 744 |
Item number |
S55 2014 |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Silverman, Richard B., |
Relator term |
author. |
245 14 - TITLE STATEMENT |
Title |
The organic chemistry of drug design and drug action / |
Statement of responsibility, etc. |
Richard B. Silverman, Mark W. Holladay. |
250 ## - EDITION STATEMENT |
Edition statement |
Third edition. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
Place of production, publication, distribution, manufacture |
San Diego, CA : |
Name of producer, publisher, distributor, manufacturer |
Elsevier/Academic Press, |
Date of production, publication, distribution, manufacture, or copyright notice |
2014 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
xviii, 517 pages : |
Other physical details |
illustrations (some color) ; |
Dimensions |
29 cm |
336 ## - CONTENT TYPE |
Content type term |
text |
Source |
rdacontent |
337 ## - MEDIA TYPE |
Media type term |
unmediated |
Source |
rdamedia |
338 ## - CARRIER TYPE |
Carrier type term |
volume |
Source |
rdacarrier |
504 ## - BIBLIOGRAPHY, ETC. NOTE |
Bibliography, etc. note |
Includes bibliographical references and index. |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Introduction -- Lead discovery and lead modification -- Receptors -- Enzymes -- Enzyme inhibition and inactivation -- Dna-interactive agents -- Drug resistance and drug synergism -- Drug metabolism -- Prodrugs and drug delivery systems. |
650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Chemistry, Pharmaceutical |
Authority record control number or standard number |
https://id.nlm.nih.gov/mesh/D002626 |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Chemistry, Organic |
Authority record control number or standard number |
https://id.nlm.nih.gov/mesh/D002625 |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Drug Design |
Authority record control number or standard number |
https://id.nlm.nih.gov/mesh/D015195 |
650 22 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name entry element |
Pharmacokinetics |
Authority record control number or standard number |
https://id.nlm.nih.gov/mesh/D010599 |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Holladay, Mark W., |
Relator term |
author. |
850 ## - HOLDING INSTITUTION |
Holding institution |
Kuakarun Nursing Library |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
National Library of Medicine Classification |
Koha item type |
General Book |
Koha issues (borrowed), all copies |
1 |
998 ## - STAFF NAME (NMU) |
Cataloger |
nuch |